Search - tctmd.com

Displaying 441 - 460 of 534

Sort: Relevancy | Date

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

News Daily News

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

November 02, 2014

News Daily News

Trial Shows Evolution of Endovascular Stroke Treatment Over Time

Todd Neale

October 24, 2014

News Daily News

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Yael L. Maxwell

October 24, 2014

News Daily News

El Ensayo Revela la Evolución del Tratamiento Endovascular de ACV con el Paso el Tiempo

Todd Neale

October 24, 2014

News Daily News

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

Yael L. Maxwell

October 10, 2014

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

News Conference News TCT 2014

AUC ‘Here to Stay’ but Should Evolve, Expert Says

September 15, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Daily News

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

L.A. McKeown

September 11, 2014

News Daily News

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

L.A. McKeown

September 11, 2014

News Industry News

Corindus Vascular Robotics Highlights Radiation Reduction at TCT Meeting

September 11, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Industry News

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

September 03, 2014

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Industry News

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

July 29, 2014

News Industry News

SORIN GROUP CELEBRATES DELIVERY OF 10,000TH HEART- LUNG MACHINE

July 10, 2014

News Industry News

Cook Medical reintroduces its Evolution® RL lead extraction products to the United States market

July 10, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

Advertisement

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

Trial Shows Evolution of Endovascular Stroke Treatment Over Time

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

El Ensayo Revela la Evolución del Tratamiento Endovascular de ACV con el Paso el Tiempo

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

AUC ‘Here to Stay’ but Should Evolve, Expert Says

TCT Course Director Outlines Current TAVR Controversies

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

Corindus Vascular Robotics Highlights Radiation Reduction at TCT Meeting

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

SORIN GROUP CELEBRATES DELIVERY OF 10,000TH HEART- LUNG MACHINE

Cook Medical reintroduces its Evolution® RL lead extraction products to the United States market

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content